2m 2m 2m 2m 2m 2m 2m
PHATHOM PHARMA (PHAT)
NASDAQ
$10.80-$0.11 (-1.02%)
Price as of Jul 14, 2026 4:17 AM EDT- $1.0BMarket Cap
- 20.47%1-Year Change
- BiotechnologyIndustry
PHATHOM PHARMA (PHAT)
$10.80-$0.11 (-1.02%)
Earnings Score
Valuation | PHAT | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | 0 | ||
Low Earnings Volatility | 2 |
Momentum Score
Valuation | PHAT | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -16.85% | ||
12-Month Momentum | 6.97% | ||
3-Month Risk Adjusted Momentum | -64.58% | ||
12-Month Risk Adjusted Momentum | 11.80% |
True Yield
Valuation | PHAT | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 0.03% | ||
Net Debt Paydown Yield | 5.86% |
Financial Health Score
Valuation | PHAT | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 4 |